Showing Results for
- Academic Journals (12,940)
Search Results
- 12,940
Academic Journals
- 12,940
-
From:Nurse Practitioners' Prescribing Reference (Vol. 22, Issue 4) Peer-Reviewed> ADVAIR DISKUS 100/50 Rx GlaxoSmithKline Steroid + long-acting beta-2 agonist. Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS 500/50 Rx...
-
From:Nurse Practitioners' Prescribing Reference (Vol. 21, Issue 1) Peer-ReviewedThe FDA has approved Anoro Ellipta (umeclidinium and vilanterol; GlaxoSmithKline and Theravance) inhalation powder for the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic...
-
From:Nurse Practitioners' Prescribing Reference (Vol. 20, Issue 3) Peer-ReviewedACCUNEB DEY Rx beta-2 agonist. Albuterol (as sulfate) 0.63mg/3mL (0.021%), 1.25mg/3mL (0.042%); soln for inh; preservative-free. Indications: Bronchospasm. Adults: Not recommended. Children: <2yrs: not...
-
From:Nurse Practitioners' Prescribing Reference (Vol. 23, Issue 1) Peer-ReviewedADVAIR DISKUS 100/50 Rx GlaxoSmithKline Steroid + long-acting beta-2 agonist. Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS 500/50 Rx Fluticasone...
-
From:Physician Assistants' Prescribing Reference (Vol. 17, Issue 1)Spiriva HandiHaler (tiotropium powder for oral inhalation, from Boehringer Ingelheim and Pfizer) has been approved by the FDA for the reduction of exacerbations in patients with chronic obstructive pulmonary disease...
-
From:MPR - Physician Assistants' Edition (Vol. 21, Issue 1)The FDA has approved Anoro Ellipta (umeclidinium and vilanterol; GlaxoSmithKline and Theravance) inhalation powder for the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic...
-
From:MPR - Physician Assistants' Edition (Vol. 20, Issue 3)The FDA has approved Breo Ellipta (fluticasone furoate and vilanterol trifenatate; GSK and Theravance) inhalation powder for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary...
-
From:Nurse Practitioners' Prescribing Reference (Vol. 14, Issue 4) Peer-ReviewedCompany: Dey, L.P. Rx Pharmacologic class: Long acting [[beta].sub.2]-agonist Active ingredient:. Formoterol (as fumarate) 20mcg/2mL; soln for inh. Indication: Long-term maintenance treatment of COPD-associated...
-
From:Nurse Practitioners' Prescribing Reference (Vol. 16, Issue 2) Peer-ReviewedAstraZeneca's Symbicort 160/4.5 micrograms (budesonide/formoterol fumarate dehydrate), a corticosteroid and long-acting [[beta].sub.2]-agonist, has been approved for the maintenance treatment of airflow obstruction in...
-
From:Physician Assistants' Prescribing Reference (Vol. 14, Issue 4)Company: Dey, L.P. Rx Pharmacologic class: Long acting [[beta].sub.2]-agonist Active ingredient: Formoterol (as fumarate) 20mcg/2mL; soln for inh. Indication: Long-term maintenance treatment of COPD-associated...
-
From:Nurse Practitioners' Prescribing Reference (Vol. 20, Issue 3) Peer-ReviewedThe FDA has approved Breo Ellipta (fluticasone furoate and vilanterol trifenatate; GSK and Theravance) inhalation powder for the maintenance treatment of airflow obstruction in patients with chronic obstructive...
-
From:Nurse Practitioners' Prescribing Reference (Vol. 21, Issue 1) Peer-ReviewedACCUNEB DEY Rx beta-2 agonist. Albuterol (as sulfate) 0.63mg/3mL (0.021%), 1.25mg/3mL (0.042%); soln for inh; preservative-free. Indications: Bronchospasm. Adults: Not recommended. Children: < 2yrs: not...
-
From:Nurse Practitioners' Prescribing Reference (Vol. 18, Issue 4) Peer-ReviewedCombivent Respimat (ipratropium bromide and albuterol; Boehringer Ingelheim), a propellant-free metered dose inhalation spray that uses a slowmoving mist, has been approved for the treatment of chronic obstructive...
-
From:MPR - Physician Assistants' Edition (Vol. 21, Issue 3)Incruse Ellipta (umeclidinium; GlaxoSmithKline) inhaler has been approved for the long-term, once daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD),...
-
From:MPR - Physician Assistants' Edition (Vol. 23, Issue 1)Company: Novartis Rx Pharmacologic class: Long-acting anticholinergic Active ingredients: Glycopyrrolate 15.6mcg; per capsule; dry powder for oral inhalation for use with Neohaler device; contains lactose....
-
From:Physician Assistants' Prescribing Reference (Vol. 16, Issue 2)AstraZeneca's Symbicort 160/4.5 micrograms (budesonide/formoterol fumarate dehydrate), a corticosteroid and long-acting [[beta].sub.2]-agonist, has been approved for the maintenance treatment of airflow obstruction in...
-
From:Journal of OsteoporosisPeer-ReviewedBackground. Osteoporosis is an extrapulmonary effect of chronic obstructive pulmonary disease (COPD). Diagnosis of osteoporosis is based on BMD measured by DXA-scan. The best location for BMD measurement in COPD has not...
-
From:Imaging in Medicine (Vol. 6, Issue 1)Author(s): Damien Pike aff1 , Tamas J Lindenmaier aff1 , Don D Sin aff3 , Grace Parraga [*] aff1 Keywords : * atherosclerosis; computed tomography; COPD; intima-media thickness; MRI; ultrasound Background &...
-
From:Clinical Practice (Vol. 11, Issue 3) Peer-ReviewedAuthor(s): Anthony D D'Urzo [*] aff1 , M Reza Maleki-Yazdi aff2 , R Andrew McIvor aff3 Keywords: bronchodilation; chronic obstructive pulmonary disease; cost of illness; epidemiology; Global Initiative for Chronic...
-
From:Obesity, Fitness & Wellness Week2015 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Cardiovascular Research. According to news originating from Groningen, Netherlands,...